Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Biogen swoops to appoint Ex-Roche Vice President

March 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen

Biogen have appointed Anirvan Ghosh to the position of Senior Vice President of research and Early Development. Ghosh is slated …
Appointment

NICE reverses decision on medication for relapsing multiple sclerosis

March 16, 2017 Sales and Marketing Biogen, zinbryta

The current topic of discussion regarding NICE is how its recent changes will impact patient access to medicine but, away …
News

The rising threat of antibiotic resistance

March 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance

Last month, researchers from the University of California, Los Angeles (UCLA) revealed findings that showed that utilising antibiotics in combination …
Feature

NICE drug expense limit of £20 million could cause treatment delays

March 16, 2017 Medical Communications, Sales and Marketing NHS England, NICE, fast-track appraisal process, rare disease

NICE has released its decision on the fast-track approval process and other changes that will be brought through at the …
News

Trump’s proposed budget doubles FDA regulatory fees

March 16, 2017 Sales and Marketing FDA, Trump

Trump’s presidency could cost the industry more than twice as much in regulatory review fees next year, as his administration …
News

NICE recommends against Opdivo for classical Hodgkin lymphoma

March 15, 2017 Research and Development, Sales and Marketing BMS, classical Hodgkin Lymphoma, opdivo

The National Institute of Health and Care Excellence (NICE) has released draft guidance provisionally turning down Bristol-Myers Squibb’s Opdivo (nivolumab) …
News

MSD’s Keytruda notches another FDA approval in Hodgkin lymphoma

March 15, 2017 Research and Development, Sales and Marketing Hodgkin lymphoma, MSD, keytruda

MSD, otherwise known as Merck in North America, continues to score indication successes with Keytruda, this time in Hodgkin lymphoma. …
News

Patients in UK to be given early access to Sanofi’s eczema treatment

March 14, 2017 Research and Development, Sales and Marketing Dupilumab, MHRA, Sanofi

Sanofi’s treatment for atopic dermatitis, otherwise known as eczema, has been given a positive scientific opinion through the MHRA’s Early …
News

Novartis secures first-line FDA approval in breast cancer indication

March 14, 2017 Manufacturing and Production, Sales and Marketing Kisqali, Novartis, breast cancer

The FDA has approved Kisqali (ribociclib) in combination with letrozole for the first-line treatment of postmenopausal women with hormone receptor …
News

XTuit Pharmaceuticals move to appoint biotech veteran as CEO

March 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing XTuit Pharmaceuticals

XTuit Pharmaceuticals has revealed the appointment of Deborah Dunshire as its new President and CEO. XTuit Pharmaceuticals is a biotech …
Appointment

Mylan’s pathway to launch of biosimilar to Herceptin cleared by Roche

March 13, 2017 Manufacturing and Production, Sales and Marketing Genentech, Herceptin, Mylan, Roche, biosimilar

Mylan scored a big victory in its plan to launch its biosimilar to Roche’s blockbuster, Herceptin, after Roche and itself …
News

Immunotherapy: The three major treatments that are changing cancer prognoses

March 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Cancer, MSD, Roche, immunotherapy, keytruda, oncology, opdivo, tecentriq

The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space. However, …
Feature

Combination immunotherapy shows promise in castration-resistant prostate cancer

March 13, 2017 Research and Development, Sales and Marketing prostate cancer

Researchers at the University of Texas MD Anderson Cancer Center have found that castration-resistant prostate cancer responds well to a …
News

Bad start to month for Karyopharm gets worse with clinical hold

March 13, 2017 Sales and Marketing Karyopharm

Coming just over a week after Karyopharm Therapeutics had announced that its lead drug had failed in a Phase 2 …
News

Pfizer announces partnership with UK university

March 13, 2017 Medical Communications, Sales and Marketing Pfizer, Swansea University

Pfizer and Swansea University have announced plans to collaborate on a new Innovation Hub at Swansea University’s new £450 million …
News
The Gateway to Local Adoption Series

Latest content

Major funding opportunity opens for early cancer diagnostics

September 4, 2026

Androlabs receives UK authorisation for new Testavan presentation

September 4, 2026

CEPI backs African-led Bundibugyo Ebola vaccine development

September 3, 2026

Cytomos appoints life sciences executive to board

September 2, 2026

Cell therapy partnership aims to bring liver disease treatment closer to US patients

September 1, 2026